APA

Maroufi N. F., Vahedian V., Akbarzadeh M., Mohammadian M., Zahedi M., Isazadeh A., Pouremamali F., Taefehshokr S., Heidari M., Rashidi M. & Nouri M. (20210111). The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. : Breast cancer (Tokyo, Japan).

Chicago

Maroufi Nazila Fathi, Vahedian Vahid, Akbarzadeh Maryam, Mohammadian Mahshid, Zahedi Mohammadsaeid, Isazadeh Alireza, Pouremamali Farhad, Taefehshokr Sina, Heidari Masoud, Rashidi Mohammadreza and Nouri Mohammad. 20210111. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. : Breast cancer (Tokyo, Japan).

Harvard

Maroufi N. F., Vahedian V., Akbarzadeh M., Mohammadian M., Zahedi M., Isazadeh A., Pouremamali F., Taefehshokr S., Heidari M., Rashidi M. and Nouri M. (20210111). The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. : Breast cancer (Tokyo, Japan).

MLA

Maroufi Nazila Fathi, Vahedian Vahid, Akbarzadeh Maryam, Mohammadian Mahshid, Zahedi Mohammadsaeid, Isazadeh Alireza, Pouremamali Farhad, Taefehshokr Sina, Heidari Masoud, Rashidi Mohammadreza and Nouri Mohammad. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. : Breast cancer (Tokyo, Japan). 20210111.